Tc-99m-labeled human polyclonal immunoglobulin G (HIG) scintigraphy in Sjögren's syndrome. 2002

Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
Department of Nuclear Medicine, University of Vienna, Austria. georg.karanikas@akh-wien.ac.at

OBJECTIVE To evaluate the usefulness of Tc-99m-HIG scintigraphy in patients with Sjögren's syndrome. METHODS Twelve consecutive patients with verified secondary Sjögren's syndrome were included in this prospective study. The control group consisted of seven patients with Lupus erythematosus; none of them showed clinical signs of Sjögren's syndrome. Planar and SPECT images of the head were performed six hours after i.v. administration of Tc-99m HIG. RESULTS Eleven out of twelve patients with secondary Sjögren's syndrome showed a positive result, while one was false negative. Tracer accumulation in patients with positive scintigraphy varied. All patients of the control group were negative. CONCLUSIONS Our data in a limited number of patients suggest that Tc-99m HIG scintigraphy could be a modality with high sensitivity and specificity for the diagnosis of Sjögren's syndrome and can provide objective information on the severity of the disease.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D012859 Sjogren's Syndrome Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Sicca Syndrome,Sjogren Syndrome,Sjogrens Syndrome,Syndrome, Sicca,Syndrome, Sjogren's
D013670 Sodium Pertechnetate Tc 99m A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints. Pertechnetate Sodium,Tc 99m-Pertechnetate,Technetium Tc 99m Pertechnetate,99Tc-Pertechnetate,99TcmO4,99mTcO4,Pertechnetate,Technetium Pertechnetate,Technetium Tc 99m O(4),Technetium-99mTc-pertechnetate,99Tc Pertechnetate,99m-Pertechnetate, Tc,Pertechnetate, Technetium,Sodium, Pertechnetate,Tc 99m Pertechnetate,Technetium 99mTc pertechnetate

Related Publications

Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
June 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
November 2002, Annals of nuclear medicine,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
November 2002, Clinical nuclear medicine,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
April 1997, Clinical nuclear medicine,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
August 1994, Clinical nuclear medicine,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
September 2000, Clinical nuclear medicine,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
September 1998, Medicina clinica,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
April 2006, Annals of nuclear medicine,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
January 1997, Clinical nuclear medicine,
Georgios Karanikas, and Klaus Bobacz, and Alexander Becherer, and Karoline Wiesner, and Robert Dudczak, and Klaus Machold, and Kurt Kletter
September 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!